Venom immunotherapy update

Honey bee on top of a flower

After a shortage of venom immunotherapy for honey bee, paper wasp and yellow jacket wasp, Stallergernes Greer has informed A&AA that changes in the United States of America production of the immunotherapy (i.e. ability to produce at another site) has increased supply in Australia. Please speak with your doctor if your immunotherapy regime was changed because of the venom immunotherapy shortage. Those with bee or wasp allergy who are at risk of anaphylaxis should speak with their GP about a referral to a clinical immunology/allergy specialist to discuss immunotherapy.  

 

 

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.